Related Experiment Video
Updated: Sep 16, 2025

Preparation of Exosomes for siRNA Delivery to Cancer Cells
Published on: December 5, 2018
Exosome-Mediated Strategies for Melanoma Eradication: A Comprehensive Review
Lalit Kumar1, Ritesh Rana2, Isha Singh3
1Department of Pharmaceutics, GNA School of Pharmacy, GNA University, Phagwara, Punjab 144401, India.
Exosomes show promise for melanoma treatment by improving drug delivery and reducing side effects. Further research is needed to overcome challenges in scalability and immunogenicity for clinical application.
Area of Science:
- Biomedical Engineering
- Oncology
- Nanomedicine
Background:
- Exosomes are natural nanovesicles with potential for melanoma therapy due to biocompatibility and stability.
- They offer advantages over conventional treatments by overcoming limitations like drug resistance and systemic toxicity.
Purpose of the Study:
- To review the therapeutic applications of exosomes in melanoma treatment.
- To highlight the potential of exosomes in overcoming challenges associated with current melanoma therapies.
Main Methods:
- A comprehensive literature search was conducted on PubMed, ScienceDirect, and Google Scholar (2015-2024).
- Keywords included "exosomes," "melanoma," and "chemotherapy."
- Studies focused on exosome-based therapeutics for melanoma were included; exosome characterization or non-melanoma studies were excluded.
Main Results:
- Exosome-delivered drugs (siRNA, chemotherapeutics) showed 2.5x greater bioavailability and 60-90% tumor reduction compared to free drugs.
- Surface modifications (e.g., cRGD peptides) enhanced exosome targeting capabilities.
- Exosome-mediated photodynamic therapy increased reactive oxygen species and induced apoptosis.
Conclusions:
- Exosomes offer a novel approach to melanoma treatment, addressing drug resistance and toxicity.
- Challenges remain in scalability and immunogenicity, requiring standardized protocols.
- Further research and clinical trials are essential to optimize exosome-based melanoma therapies.
More Related Videos
07:41A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
08:50Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
Published on: August 16, 2024
Related Concept Videos
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...